4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001951287-26-000002
Options or other derivatives
- Chief Commercial Officer acquired 240,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Karas Eric Chief Commercial Officer | 2026-01-02 | Grant or award · Stock option (right to buy) | +240,000 | 240,000 | D | ||
Loading xslF345X05/form4-01052026_090126.xml…